Figure 3.
MiR-222 regulates HepG2 cell cycle progression. A: MiR-222 mimic increased the percentage of HepG2 cells in S phase and decreased that in G2 phase (n = 3). B: MiR-222 inhibitor decreased the percentage of HepG2 cells in S phase and increased that in G2 phase (n = 3). **P < 0.01.